A new model for predicting infectious complications during fludarabine‐based combination chemotherapy among patients with indolent lymphoid malignancies

BACKGROUND Fludarabine‐containing combination chemotherapy regimens are increasingly used in the treatment of indolent lymphoid malignancies, with the associated risk of infection being the major toxicity. Predictors of infection during fludarabine‐containing combination therapy are poorly defined a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2004-11, Vol.101 (9), p.2042-2049
Hauptverfasser:	Tam, Constantine S., Wolf, Max M., Januszewicz, E. Henry, Grigg, Andrew P., Prince, H. Miles, Westerman, David, Seymour, John F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Female fludarabine chemotherapy Hematologic and hematopoietic diseases Humans Leukemia - complications Leukemia - drug therapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis lymphoid malignancies Lymphoma - complications Lymphoma - drug therapy Male Medical sciences Middle Aged Neoplasm Staging opportunistic infection Opportunistic Infections - etiology purine analog Risk Factors Tumors Vidarabine - administration & dosage Vidarabine - adverse effects Vidarabine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!